Fight ARDS - Buy DSCO For FDA Approval TomorrowSurfaxin
. Discovery Labs' first product based on KL4 technology is SURFAXIN
® ... SURFAXIN
® (lucinactant) is an investigational drug product not approved for use, ...
Letter for Surfaxin
for the prevention of Respiratory Distress Syndrome (RDS) in ... potential approval of the Surfaxin
New Drug Application (NDA) ...
Surfaxin New Drug ApplicationSurfaxin
information includes news, clinical trial results and side effects. ... Discovery Labs Reports On Surfaxin
End of Review Meeting With FDA - July 2, 2009 ...
Biological ... Surfaxin
is comprised of four active pharmaceutical ingredients ... We are positioning Surfaxin
, the first peptide-containing, ...
FDA rejects Discovery Labs' Surfaxin - FierceBiotech
Shares of Discovery Laboratories plunged today as the FDA announced that it wouldn't approve the company's drug Surfaxin
for treatment of respiratory illness in ...
Surfaxin for respiratory diseases by Discovery Laboratories.
Surfactants are compositions, which are produced naturally in the lungs and essential for breathing. ... SURFAXIN
, if approved, would be the ...